Grifols | GRFS - Pre Tax Profit

Stock Price
8.98
Daily Change
0.02 0.22%
Monthly
-2.29%
Yearly
6.40%
Q1 Forecast
9.14

Grifols reported EUR66.98M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Arca Biopharma USD -21M 4.78M Mar/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -2.85M 99K Mar/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Grifols EUR 66.98M 19.92M Jun/2024
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024